Maria J. Edwards

Array ( [id] => 5374629 [patent_doc_number] => 20090312190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses' [patent_app_type] => utility [patent_app_number] => 12/094503 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18030 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312190.pdf [firstpage_image] =>[orig_patent_app_number] => 12094503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539136 [patent_doc_number] => 20090220941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/091665 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14228 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220941.pdf [firstpage_image] =>[orig_patent_app_number] => 12091665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054617 [patent_doc_number] => 20110110977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Multiclade HIV Vaccines' [patent_app_type] => utility [patent_app_number] => 12/083905 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21115 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110977.pdf [firstpage_image] =>[orig_patent_app_number] => 12083905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502327 [patent_doc_number] => 08034355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase' [patent_app_type] => utility [patent_app_number] => 12/089353 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14392 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034355.pdf [firstpage_image] =>[orig_patent_app_number] => 12089353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204503 [patent_doc_number] => 20070025983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Compounds capable of inhibiting HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/544346 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9115 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20070025983.pdf [firstpage_image] =>[orig_patent_app_number] => 11544346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193527 [patent_doc_number] => 20070082011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Recombinant proteins from filoviruses and their use' [patent_app_type] => utility [patent_app_number] => 11/545093 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19857 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082011.pdf [firstpage_image] =>[orig_patent_app_number] => 11545093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004559 [patent_doc_number] => 20070202127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 11/529806 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 37619 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202127.pdf [firstpage_image] =>[orig_patent_app_number] => 11529806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952341 [patent_doc_number] => 20110033446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication' [patent_app_type] => utility [patent_app_number] => 11/528431 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12719 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033446.pdf [firstpage_image] =>[orig_patent_app_number] => 11528431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5241788 [patent_doc_number] => 20070020280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Compositions and methods for inhibition of HIV-1 infection' [patent_app_type] => utility [patent_app_number] => 11/520556 [patent_app_country] => US [patent_app_date] => 2006-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 21986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020280.pdf [firstpage_image] =>[orig_patent_app_number] => 11520556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101763 [patent_doc_number] => 20070185025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Filoviral immunosuppressive peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/518641 [patent_app_country] => US [patent_app_date] => 2006-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29001 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185025.pdf [firstpage_image] =>[orig_patent_app_number] => 11518641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5106974 [patent_doc_number] => 20070065852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'HIV recombinant vaccine' [patent_app_type] => utility [patent_app_number] => 11/512315 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11768 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065852.pdf [firstpage_image] =>[orig_patent_app_number] => 11512315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7773024 [patent_doc_number] => 08119140 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins' [patent_app_type] => utility [patent_app_number] => 11/990222 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 28 [patent_no_of_words] => 9571 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119140.pdf [firstpage_image] =>[orig_patent_app_number] => 11990222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733477 [patent_doc_number] => 20060258594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/491755 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23609 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258594.pdf [firstpage_image] =>[orig_patent_app_number] => 11491755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204960 [patent_doc_number] => 20070026441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Methods for reducing viral load in HIV-1-infected patients' [patent_app_type] => utility [patent_app_number] => 11/491330 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 31709 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026441.pdf [firstpage_image] =>[orig_patent_app_number] => 11491330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187014 [patent_doc_number] => 20110124842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Peptide that binds to a broadly neutralizing anti-HIV antibody-structure of 4E10 Fab fragment complex, uses thereof, compositions therefrom' [patent_app_type] => utility [patent_app_number] => 11/489162 [patent_app_country] => US [patent_app_date] => 2006-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 101275 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124842.pdf [firstpage_image] =>[orig_patent_app_number] => 11489162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839868 [patent_doc_number] => 20080280354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus' [patent_app_type] => utility [patent_app_number] => 11/486535 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7810 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280354.pdf [firstpage_image] =>[orig_patent_app_number] => 11486535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921452 [patent_doc_number] => 20060240042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'IMMUNOGENICITY USING A COMBINATION OF DNA AND VACCINIA VIRUS VECTOR VACCINES' [patent_app_type] => utility [patent_app_number] => 11/428815 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240042.pdf [firstpage_image] =>[orig_patent_app_number] => 11428815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242126 [patent_doc_number] => 20070020619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its applications' [patent_app_type] => utility [patent_app_number] => 11/480014 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9386 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020619.pdf [firstpage_image] =>[orig_patent_app_number] => 11480014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070177 [patent_doc_number] => 20110045027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Adjuvant' [patent_app_type] => utility [patent_app_number] => 11/917961 [patent_app_country] => US [patent_app_date] => 2006-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 32108 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045027.pdf [firstpage_image] =>[orig_patent_app_number] => 11917961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318468 [patent_doc_number] => 07521177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence' [patent_app_type] => utility [patent_app_number] => 11/424127 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521177.pdf [firstpage_image] =>[orig_patent_app_number] => 11424127 [rel_patent_id] =>[rel_patent_doc_number] =>)